(Q46253882)

20 December 2017

title

Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001. (English)

1 reference

20 December 2017

1 reference

Riitta Koivisto-Korander

1

1 reference

20 December 2017

Ralf Butzow

2

1 reference

20 December 2017

Anna-Maija Koivisto

3

1 reference

20 December 2017

Arto Leminen

4

1 reference

20 December 2017

language of work or name

English

0 references

publication date

26 July 2008

1 reference

20 December 2017

published in

Gynecologic Oncology

1 reference

20 December 2017

volume

111

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

74-81

1 reference

20 December 2017

Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Prognostic factors and treatment modalities in uterine sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

The role of surgery and treatment trends in uterine sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990-2003).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

The management of patients with uterine sarcoma: a debated clinical challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

7 January 2021

Gynaecological sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Early-stage carcinosarcoma of the uterus: the significance of lymph node count

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Systemic therapy for advanced uterine sarcoma: a systematic review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Uterine sarcoma: steroid receptors and response to hormonal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Uterine sarcomas in breast cancer patients treated with tamoxifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Association of tamoxifen and uterine sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Phase III Trial of Ifosfamide With or Without Paclitaxel in Advanced Uterine Carcinosarcoma: A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Mifepristone as treatment of recurrent progesterone receptor-positive uterine leiomyosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Endometrial stromal sarcoma: objective response to letrozole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.06.002

10.1016/J.YGYNO.2008.06.002

7 January 2021

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017